These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29761663)

  • 1. A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image-guided intensity-modulated radiation therapy.
    Soukup A; Meier V; Pot S; Voelter K; Rohrer Bley C
    Vet Comp Oncol; 2018 Dec; 16(4):441-449. PubMed ID: 29761663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using biologically based objectives to optimize boost intensity-modulated radiation therapy planning for brainstem tumors in dogs.
    Meier V; Besserer J; Rohrer Bley C
    Vet Radiol Ultrasound; 2020 Jan; 61(1):77-84. PubMed ID: 31600027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs.
    Meier V; Staudinger C; Körner M; Soukup A; Rohrer Bley C
    Vet Radiol Ultrasound; 2022 Sep; 63(5):633-648. PubMed ID: 35347801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017).
    Stevens A; Turek M; Vail D; Christensen N; Forrest L
    Vet Radiol Ultrasound; 2020 Nov; 61(6):718-725. PubMed ID: 32713101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of local residual disease and local failure after intensity modulated/image guided radiation therapy for sinonasal tumors in dogs.
    Poirier VJ; Koh ESY; Darko J; Fleck A; Pinard C; Vail DM
    J Vet Intern Med; 2021 Mar; 35(2):1062-1072. PubMed ID: 33660342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective assessment of radiation toxicity from a definitive-intent, moderately hypofractionated image-guided intensity-modulated protocol for anal sac adenocarcinoma in dogs.
    Körner M; Staudinger C; Meier V; Rohrer Bley C
    Vet Comp Oncol; 2022 Mar; 20(1):8-19. PubMed ID: 33890343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and periocular radiation toxicity in dogs treated for sinonasal tumors: A critical review.
    Wolf F; Meier VS; Pot SA; Rohrer Bley C
    Vet Ophthalmol; 2020 Jul; 23(4):596-610. PubMed ID: 32281234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RADIATION THERAPY COMMUNICATION-REIRRADIATION OF A NASAL TUMOR IN A BRACHYCEPHALIC DOG USING INTENSITY MODULATED RADIATION THERAPY.
    Rancilio NJ; Custead MR; Poulson JM
    Vet Radiol Ultrasound; 2016 Sep; 57(5):E46-50. PubMed ID: 26729295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
    Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complication probability study for a definitive-intent, moderately hypofractionated image-guided intensity-modulated radiotherapy protocol for anal sac adenocarcinoma in dogs.
    Meier V; Besserer J; Roos M; Rohrer Bley C
    Vet Comp Oncol; 2019 Mar; 17(1):21-31. PubMed ID: 30136336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study.
    Passoni P; Reni M; Cattaneo GM; Slim N; Cereda S; Balzano G; Castoldi R; Longobardi B; Bettinardi V; Gianolli L; Gusmini S; Staudacher C; Calandrino R; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1000-6. PubMed ID: 24267968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
    Meyerhof E; Sprave T; Welte SE; Nicolay NH; Förster R; Bostel T; Bruckner T; Schlampp I; Debus J; Rief H
    Trials; 2017 Mar; 18(1):98. PubMed ID: 28253920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric impact of daily setup variations during treatment of canine nasal tumors using intensity-modulated radiation therapy.
    Deveau MA; Gutiérrez AN; Mackie TR; Tomé WA; Forrest LJ
    Vet Radiol Ultrasound; 2010; 51(1):90-6. PubMed ID: 20166402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.
    Batth SS; Sreeraman R; Dienes E; Beckett LA; Daly ME; Cui J; Mathai M; Purdy JA; Chen AM
    Br J Radiol; 2013 Dec; 86(1032):20130459. PubMed ID: 24167183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two dose calculation algorithms-anisotropic analytical algorithm and Acuros XB-for radiation therapy planning of canine intranasal tumors.
    Nagata K; Pethel TD
    Vet Radiol Ultrasound; 2017 Jul; 58(4):479-485. PubMed ID: 28464564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.